View
comments
Antidepressants could cut the risk of dying from Covid, research suggests.
Scientists in the US tracked the health of nearly 85,000 volunteers during the first year of the pandemic.
They picked out 3,401 who were prescribed selective serotonin reuptake inhibitors (SSRIs) and compared them to similar adults.
Results showed patients taking fluoxetine, branded as Prozac and sold for as little as 4p a pill, were 28 per cent less likely to die of Covid.
The effect was also visible among adults taking fluvoxamine, marketed as Luvox.
Doctors at the University of California, San Francisco, who carried out the research, said the results were 'encouraging'.
Scientists found that taking fluoxetine, branded as Prozac and sold for 4p a pill, slashed the risk of death in Covid patients by 28 per cent. The powerful effects were also visible in adults taking Luvox, priced at 29p a pill, who had the risk slashed by 26 per cent
